Icahn increased IEP holdings by 24 million shares; IEP represents ~48% of his portfolio. IEP is down about 80%, yet Icahn doubled down on the position. Icahn fully exited Bausch Health, signaling capitulation on that recovery. He added EchoStar (SATS) and boosted several other selective stakes.
IEP reported a $0.19 earnings loss, missing profit expectations. Quarterly sales of $2.558 billion exceeded estimates but fell 5.1% year over year. Adjusted EBITDA improved to $12 million from $9 million last year. Net asset value declined by $223 million, mainly due to losses in CVR Energy. IEP shares fell 2.63% to $9.99 post-announcement.
Icahn Enterprises has faced significant declines, down 75% since November 2022. IEP has halved its dividend twice recently, raising concerns about credibility. Valuation practices for Viskase significantly inflate perceived asset value. Critics question IEP’s transparency and valuation methodology for its assets. Promotion of 'indicative NAV' raises doubts about IEP's financial health.
Icahn Enterprises cuts its dividend from $1 to $0.50 per share. The dividend reduction sparked a stock price plunge of over 10%. Icahn aims to acquire more shares of CVR Energy, currently 66% owned. CVR Energy's stock rose 4.1% despite Icahn Enterprises' decline. Icahn notes significant opportunities exist in the current undervalued market.
IEP stock dropped 9% due to potential dividend cut. Icahn plans to increase stake in CVR Energy by 20%. CVR's stock fell 45% YTD, underperforming S&P 500. IEP to propose tender offer for CVR at $17.50/share. Icahn finds current market valuations as extreme and offers opportunities.
Icahn plans to increase IEP's stake in CVR Energy by over 20%. IEP's dividend is being halved to fund future investments and IEP's war chest. CVR shares have dropped over 45% this year, creating an undervalued opportunity. Recent dividend cut affects IEP's value, which is down over 25% year-to-date. Icahn views current market as presenting significant activist opportunities.